nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—Ifosfamide—testicular cancer	0.0806	0.428	CbGbCtD
Darunavir—CYP3A4—Vinblastine—testicular cancer	0.0428	0.227	CbGbCtD
Darunavir—CYP3A4—Etoposide—testicular cancer	0.0385	0.205	CbGbCtD
Darunavir—CYP3A4—Doxorubicin—testicular cancer	0.0263	0.14	CbGbCtD
Darunavir—Feeling abnormal—Etoposide—testicular cancer	0.000473	0.000583	CcSEcCtD
Darunavir—Hyperglycaemia—Doxorubicin—testicular cancer	0.000473	0.000582	CcSEcCtD
Darunavir—Nausea—Dactinomycin—testicular cancer	0.000471	0.000581	CcSEcCtD
Darunavir—Gastrointestinal pain—Etoposide—testicular cancer	0.00047	0.000578	CcSEcCtD
Darunavir—Infestation NOS—Doxorubicin—testicular cancer	0.000467	0.000575	CcSEcCtD
Darunavir—Infestation—Doxorubicin—testicular cancer	0.000467	0.000575	CcSEcCtD
Darunavir—Visual impairment—Methotrexate—testicular cancer	0.000467	0.000575	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000463	0.00057	CcSEcCtD
Darunavir—Vomiting—Ifosfamide—testicular cancer	0.000462	0.00057	CcSEcCtD
Darunavir—Hypersensitivity—Cisplatin—testicular cancer	0.000462	0.000569	CcSEcCtD
Darunavir—Bradycardia—Epirubicin—testicular cancer	0.000461	0.000568	CcSEcCtD
Darunavir—Renal failure—Doxorubicin—testicular cancer	0.000459	0.000566	CcSEcCtD
Darunavir—Rash—Ifosfamide—testicular cancer	0.000458	0.000565	CcSEcCtD
Darunavir—Dermatitis—Ifosfamide—testicular cancer	0.000458	0.000564	CcSEcCtD
Darunavir—Erythema multiforme—Methotrexate—testicular cancer	0.000458	0.000564	CcSEcCtD
Darunavir—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000458	0.000564	CcSEcCtD
Darunavir—Urticaria—Etoposide—testicular cancer	0.000456	0.000562	CcSEcCtD
Darunavir—Haemoglobin—Epirubicin—testicular cancer	0.000455	0.000561	CcSEcCtD
Darunavir—Jaundice—Doxorubicin—testicular cancer	0.000455	0.000561	CcSEcCtD
Darunavir—Stomatitis—Doxorubicin—testicular cancer	0.000455	0.000561	CcSEcCtD
Darunavir—Body temperature increased—Etoposide—testicular cancer	0.000454	0.000559	CcSEcCtD
Darunavir—Abdominal pain—Etoposide—testicular cancer	0.000454	0.000559	CcSEcCtD
Darunavir—Hepatitis—Epirubicin—testicular cancer	0.000453	0.000558	CcSEcCtD
Darunavir—Haemorrhage—Epirubicin—testicular cancer	0.000453	0.000558	CcSEcCtD
Darunavir—Eye disorder—Methotrexate—testicular cancer	0.000453	0.000557	CcSEcCtD
Darunavir—Hypoaesthesia—Epirubicin—testicular cancer	0.000451	0.000555	CcSEcCtD
Darunavir—Asthenia—Cisplatin—testicular cancer	0.00045	0.000554	CcSEcCtD
Darunavir—Cardiac disorder—Methotrexate—testicular cancer	0.000449	0.000554	CcSEcCtD
Darunavir—Urinary tract disorder—Epirubicin—testicular cancer	0.000448	0.000551	CcSEcCtD
Darunavir—Oedema peripheral—Epirubicin—testicular cancer	0.000446	0.00055	CcSEcCtD
Darunavir—Haematuria—Doxorubicin—testicular cancer	0.000445	0.000549	CcSEcCtD
Darunavir—Connective tissue disorder—Epirubicin—testicular cancer	0.000445	0.000549	CcSEcCtD
Darunavir—Urethral disorder—Epirubicin—testicular cancer	0.000444	0.000547	CcSEcCtD
Darunavir—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000442	0.000544	CcSEcCtD
Darunavir—Epistaxis—Doxorubicin—testicular cancer	0.000441	0.000543	CcSEcCtD
Darunavir—Angiopathy—Methotrexate—testicular cancer	0.000439	0.000541	CcSEcCtD
Darunavir—Immune system disorder—Methotrexate—testicular cancer	0.000437	0.000539	CcSEcCtD
Darunavir—Visual impairment—Epirubicin—testicular cancer	0.000437	0.000538	CcSEcCtD
Darunavir—Mediastinal disorder—Methotrexate—testicular cancer	0.000436	0.000538	CcSEcCtD
Darunavir—Chills—Methotrexate—testicular cancer	0.000434	0.000535	CcSEcCtD
Darunavir—Nausea—Ifosfamide—testicular cancer	0.000432	0.000532	CcSEcCtD
Darunavir—Diarrhoea—Cisplatin—testicular cancer	0.000429	0.000528	CcSEcCtD
Darunavir—Erythema multiforme—Epirubicin—testicular cancer	0.000428	0.000528	CcSEcCtD
Darunavir—Alopecia—Methotrexate—testicular cancer	0.000428	0.000527	CcSEcCtD
Darunavir—Bradycardia—Doxorubicin—testicular cancer	0.000427	0.000526	CcSEcCtD
Darunavir—Mental disorder—Methotrexate—testicular cancer	0.000424	0.000523	CcSEcCtD
Darunavir—Eye disorder—Epirubicin—testicular cancer	0.000423	0.000522	CcSEcCtD
Darunavir—Hypersensitivity—Etoposide—testicular cancer	0.000423	0.000521	CcSEcCtD
Darunavir—Malnutrition—Methotrexate—testicular cancer	0.000422	0.000519	CcSEcCtD
Darunavir—Erythema—Methotrexate—testicular cancer	0.000422	0.000519	CcSEcCtD
Darunavir—Haemoglobin—Doxorubicin—testicular cancer	0.000421	0.000519	CcSEcCtD
Darunavir—Flushing—Epirubicin—testicular cancer	0.000421	0.000518	CcSEcCtD
Darunavir—Cardiac disorder—Epirubicin—testicular cancer	0.000421	0.000518	CcSEcCtD
Darunavir—Hepatitis—Doxorubicin—testicular cancer	0.000419	0.000516	CcSEcCtD
Darunavir—Haemorrhage—Doxorubicin—testicular cancer	0.000419	0.000516	CcSEcCtD
Darunavir—Hypoaesthesia—Doxorubicin—testicular cancer	0.000417	0.000514	CcSEcCtD
Darunavir—Urinary tract disorder—Doxorubicin—testicular cancer	0.000414	0.00051	CcSEcCtD
Darunavir—Oedema peripheral—Doxorubicin—testicular cancer	0.000413	0.000509	CcSEcCtD
Darunavir—Dysgeusia—Methotrexate—testicular cancer	0.000413	0.000508	CcSEcCtD
Darunavir—Asthenia—Etoposide—testicular cancer	0.000412	0.000508	CcSEcCtD
Darunavir—Connective tissue disorder—Doxorubicin—testicular cancer	0.000412	0.000508	CcSEcCtD
Darunavir—Angiopathy—Epirubicin—testicular cancer	0.000411	0.000506	CcSEcCtD
Darunavir—Urethral disorder—Doxorubicin—testicular cancer	0.000411	0.000506	CcSEcCtD
Darunavir—Immune system disorder—Epirubicin—testicular cancer	0.000409	0.000504	CcSEcCtD
Darunavir—Mediastinal disorder—Epirubicin—testicular cancer	0.000408	0.000503	CcSEcCtD
Darunavir—Chills—Epirubicin—testicular cancer	0.000407	0.000501	CcSEcCtD
Darunavir—Pruritus—Etoposide—testicular cancer	0.000406	0.000501	CcSEcCtD
Darunavir—Visual impairment—Doxorubicin—testicular cancer	0.000404	0.000498	CcSEcCtD
Darunavir—Alopecia—Epirubicin—testicular cancer	0.0004	0.000493	CcSEcCtD
Darunavir—Vomiting—Cisplatin—testicular cancer	0.000399	0.000491	CcSEcCtD
Darunavir—Mental disorder—Epirubicin—testicular cancer	0.000397	0.000489	CcSEcCtD
Darunavir—Erythema multiforme—Doxorubicin—testicular cancer	0.000396	0.000488	CcSEcCtD
Darunavir—Rash—Cisplatin—testicular cancer	0.000395	0.000487	CcSEcCtD
Darunavir—Dermatitis—Cisplatin—testicular cancer	0.000395	0.000486	CcSEcCtD
Darunavir—Malnutrition—Epirubicin—testicular cancer	0.000394	0.000486	CcSEcCtD
Darunavir—Erythema—Epirubicin—testicular cancer	0.000394	0.000486	CcSEcCtD
Darunavir—Diarrhoea—Etoposide—testicular cancer	0.000393	0.000484	CcSEcCtD
Darunavir—Eye disorder—Doxorubicin—testicular cancer	0.000392	0.000483	CcSEcCtD
Darunavir—Ill-defined disorder—Methotrexate—testicular cancer	0.000391	0.000482	CcSEcCtD
Darunavir—Anaemia—Methotrexate—testicular cancer	0.00039	0.00048	CcSEcCtD
Darunavir—Flushing—Doxorubicin—testicular cancer	0.000389	0.000479	CcSEcCtD
Darunavir—Cardiac disorder—Doxorubicin—testicular cancer	0.000389	0.000479	CcSEcCtD
Darunavir—Flatulence—Epirubicin—testicular cancer	0.000389	0.000479	CcSEcCtD
Darunavir—Dysgeusia—Epirubicin—testicular cancer	0.000386	0.000476	CcSEcCtD
Darunavir—Angiopathy—Doxorubicin—testicular cancer	0.00038	0.000469	CcSEcCtD
Darunavir—Malaise—Methotrexate—testicular cancer	0.00038	0.000468	CcSEcCtD
Darunavir—Dizziness—Etoposide—testicular cancer	0.00038	0.000468	CcSEcCtD
Darunavir—Muscle spasms—Epirubicin—testicular cancer	0.000379	0.000467	CcSEcCtD
Darunavir—Immune system disorder—Doxorubicin—testicular cancer	0.000379	0.000466	CcSEcCtD
Darunavir—Vertigo—Methotrexate—testicular cancer	0.000379	0.000466	CcSEcCtD
Darunavir—Mediastinal disorder—Doxorubicin—testicular cancer	0.000378	0.000465	CcSEcCtD
Darunavir—Leukopenia—Methotrexate—testicular cancer	0.000377	0.000465	CcSEcCtD
Darunavir—Chills—Doxorubicin—testicular cancer	0.000376	0.000463	CcSEcCtD
Darunavir—Nausea—Cisplatin—testicular cancer	0.000372	0.000459	CcSEcCtD
Darunavir—Alopecia—Doxorubicin—testicular cancer	0.000371	0.000456	CcSEcCtD
Darunavir—Cough—Methotrexate—testicular cancer	0.000368	0.000453	CcSEcCtD
Darunavir—Mental disorder—Doxorubicin—testicular cancer	0.000367	0.000452	CcSEcCtD
Darunavir—Ill-defined disorder—Epirubicin—testicular cancer	0.000366	0.000451	CcSEcCtD
Darunavir—Convulsion—Methotrexate—testicular cancer	0.000365	0.00045	CcSEcCtD
Darunavir—Vomiting—Etoposide—testicular cancer	0.000365	0.00045	CcSEcCtD
Darunavir—Erythema—Doxorubicin—testicular cancer	0.000365	0.00045	CcSEcCtD
Darunavir—Malnutrition—Doxorubicin—testicular cancer	0.000365	0.00045	CcSEcCtD
Darunavir—Anaemia—Epirubicin—testicular cancer	0.000365	0.000449	CcSEcCtD
Darunavir—Agitation—Epirubicin—testicular cancer	0.000363	0.000447	CcSEcCtD
Darunavir—Rash—Etoposide—testicular cancer	0.000362	0.000446	CcSEcCtD
Darunavir—Dermatitis—Etoposide—testicular cancer	0.000362	0.000446	CcSEcCtD
Darunavir—Headache—Etoposide—testicular cancer	0.00036	0.000443	CcSEcCtD
Darunavir—Flatulence—Doxorubicin—testicular cancer	0.00036	0.000443	CcSEcCtD
Darunavir—Arthralgia—Methotrexate—testicular cancer	0.000359	0.000442	CcSEcCtD
Darunavir—Myalgia—Methotrexate—testicular cancer	0.000359	0.000442	CcSEcCtD
Darunavir—Chest pain—Methotrexate—testicular cancer	0.000359	0.000442	CcSEcCtD
Darunavir—Dysgeusia—Doxorubicin—testicular cancer	0.000357	0.00044	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000356	0.000439	CcSEcCtD
Darunavir—Malaise—Epirubicin—testicular cancer	0.000356	0.000438	CcSEcCtD
Darunavir—Discomfort—Methotrexate—testicular cancer	0.000355	0.000437	CcSEcCtD
Darunavir—Vertigo—Epirubicin—testicular cancer	0.000354	0.000437	CcSEcCtD
Darunavir—Syncope—Epirubicin—testicular cancer	0.000354	0.000436	CcSEcCtD
Darunavir—Leukopenia—Epirubicin—testicular cancer	0.000353	0.000435	CcSEcCtD
Darunavir—Muscle spasms—Doxorubicin—testicular cancer	0.000351	0.000432	CcSEcCtD
Darunavir—Palpitations—Epirubicin—testicular cancer	0.000349	0.000429	CcSEcCtD
Darunavir—Confusional state—Methotrexate—testicular cancer	0.000347	0.000427	CcSEcCtD
Darunavir—Loss of consciousness—Epirubicin—testicular cancer	0.000347	0.000427	CcSEcCtD
Darunavir—Cough—Epirubicin—testicular cancer	0.000344	0.000424	CcSEcCtD
Darunavir—Convulsion—Epirubicin—testicular cancer	0.000342	0.000421	CcSEcCtD
Darunavir—Nausea—Etoposide—testicular cancer	0.000341	0.00042	CcSEcCtD
Darunavir—Hypertension—Epirubicin—testicular cancer	0.000341	0.00042	CcSEcCtD
Darunavir—Ill-defined disorder—Doxorubicin—testicular cancer	0.000339	0.000417	CcSEcCtD
Darunavir—Nervous system disorder—Methotrexate—testicular cancer	0.000337	0.000416	CcSEcCtD
Darunavir—Anaemia—Doxorubicin—testicular cancer	0.000337	0.000416	CcSEcCtD
Darunavir—Thrombocytopenia—Methotrexate—testicular cancer	0.000337	0.000415	CcSEcCtD
Darunavir—Chest pain—Epirubicin—testicular cancer	0.000336	0.000414	CcSEcCtD
Darunavir—Arthralgia—Epirubicin—testicular cancer	0.000336	0.000414	CcSEcCtD
Darunavir—Myalgia—Epirubicin—testicular cancer	0.000336	0.000414	CcSEcCtD
Darunavir—Agitation—Doxorubicin—testicular cancer	0.000335	0.000413	CcSEcCtD
Darunavir—Anxiety—Epirubicin—testicular cancer	0.000335	0.000412	CcSEcCtD
Darunavir—Skin disorder—Methotrexate—testicular cancer	0.000334	0.000412	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000334	0.000411	CcSEcCtD
Darunavir—Hyperhidrosis—Methotrexate—testicular cancer	0.000333	0.00041	CcSEcCtD
Darunavir—Discomfort—Epirubicin—testicular cancer	0.000332	0.000409	CcSEcCtD
Darunavir—Malaise—Doxorubicin—testicular cancer	0.000329	0.000405	CcSEcCtD
Darunavir—Dry mouth—Epirubicin—testicular cancer	0.000328	0.000405	CcSEcCtD
Darunavir—Vertigo—Doxorubicin—testicular cancer	0.000328	0.000404	CcSEcCtD
Darunavir—Anorexia—Methotrexate—testicular cancer	0.000328	0.000404	CcSEcCtD
Darunavir—Syncope—Doxorubicin—testicular cancer	0.000327	0.000403	CcSEcCtD
Darunavir—Leukopenia—Doxorubicin—testicular cancer	0.000327	0.000402	CcSEcCtD
Darunavir—Confusional state—Epirubicin—testicular cancer	0.000325	0.0004	CcSEcCtD
Darunavir—Palpitations—Doxorubicin—testicular cancer	0.000323	0.000397	CcSEcCtD
Darunavir—Loss of consciousness—Doxorubicin—testicular cancer	0.000321	0.000395	CcSEcCtD
Darunavir—Cough—Doxorubicin—testicular cancer	0.000318	0.000392	CcSEcCtD
Darunavir—Shock—Epirubicin—testicular cancer	0.000317	0.00039	CcSEcCtD
Darunavir—Convulsion—Doxorubicin—testicular cancer	0.000316	0.00039	CcSEcCtD
Darunavir—Nervous system disorder—Epirubicin—testicular cancer	0.000316	0.000389	CcSEcCtD
Darunavir—Thrombocytopenia—Epirubicin—testicular cancer	0.000315	0.000388	CcSEcCtD
Darunavir—Hypertension—Doxorubicin—testicular cancer	0.000315	0.000388	CcSEcCtD
Darunavir—Tachycardia—Epirubicin—testicular cancer	0.000314	0.000387	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000313	0.000386	CcSEcCtD
Darunavir—Skin disorder—Epirubicin—testicular cancer	0.000313	0.000385	CcSEcCtD
Darunavir—Hyperhidrosis—Epirubicin—testicular cancer	0.000311	0.000383	CcSEcCtD
Darunavir—Insomnia—Methotrexate—testicular cancer	0.000311	0.000383	CcSEcCtD
Darunavir—Myalgia—Doxorubicin—testicular cancer	0.000311	0.000383	CcSEcCtD
Darunavir—Arthralgia—Doxorubicin—testicular cancer	0.000311	0.000383	CcSEcCtD
Darunavir—Chest pain—Doxorubicin—testicular cancer	0.000311	0.000383	CcSEcCtD
Darunavir—Anxiety—Doxorubicin—testicular cancer	0.00031	0.000381	CcSEcCtD
Darunavir—Paraesthesia—Methotrexate—testicular cancer	0.000309	0.000381	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000309	0.00038	CcSEcCtD
Darunavir—Discomfort—Doxorubicin—testicular cancer	0.000307	0.000378	CcSEcCtD
Darunavir—Anorexia—Epirubicin—testicular cancer	0.000307	0.000378	CcSEcCtD
Darunavir—Dyspnoea—Methotrexate—testicular cancer	0.000307	0.000378	CcSEcCtD
Darunavir—Somnolence—Methotrexate—testicular cancer	0.000306	0.000377	CcSEcCtD
Darunavir—Dry mouth—Doxorubicin—testicular cancer	0.000304	0.000374	CcSEcCtD
Darunavir—Dyspepsia—Methotrexate—testicular cancer	0.000303	0.000373	CcSEcCtD
Darunavir—Confusional state—Doxorubicin—testicular cancer	0.0003	0.00037	CcSEcCtD
Darunavir—Decreased appetite—Methotrexate—testicular cancer	0.000299	0.000368	CcSEcCtD
Darunavir—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000297	0.000366	CcSEcCtD
Darunavir—Fatigue—Methotrexate—testicular cancer	0.000297	0.000365	CcSEcCtD
Darunavir—Pain—Methotrexate—testicular cancer	0.000294	0.000362	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000293	0.000361	CcSEcCtD
Darunavir—Shock—Doxorubicin—testicular cancer	0.000293	0.000361	CcSEcCtD
Darunavir—Nervous system disorder—Doxorubicin—testicular cancer	0.000292	0.00036	CcSEcCtD
Darunavir—Thrombocytopenia—Doxorubicin—testicular cancer	0.000292	0.000359	CcSEcCtD
Darunavir—Insomnia—Epirubicin—testicular cancer	0.000291	0.000359	CcSEcCtD
Darunavir—Tachycardia—Doxorubicin—testicular cancer	0.000291	0.000358	CcSEcCtD
Darunavir—Skin disorder—Doxorubicin—testicular cancer	0.000289	0.000356	CcSEcCtD
Darunavir—Paraesthesia—Epirubicin—testicular cancer	0.000289	0.000356	CcSEcCtD
Darunavir—Hyperhidrosis—Doxorubicin—testicular cancer	0.000288	0.000355	CcSEcCtD
Darunavir—Dyspnoea—Epirubicin—testicular cancer	0.000287	0.000354	CcSEcCtD
Darunavir—Somnolence—Epirubicin—testicular cancer	0.000286	0.000353	CcSEcCtD
Darunavir—Anorexia—Doxorubicin—testicular cancer	0.000284	0.00035	CcSEcCtD
Darunavir—Feeling abnormal—Methotrexate—testicular cancer	0.000283	0.000349	CcSEcCtD
Darunavir—Dyspepsia—Epirubicin—testicular cancer	0.000283	0.000349	CcSEcCtD
Darunavir—Gastrointestinal pain—Methotrexate—testicular cancer	0.000281	0.000347	CcSEcCtD
Darunavir—Decreased appetite—Epirubicin—testicular cancer	0.00028	0.000345	CcSEcCtD
Darunavir—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000278	0.000342	CcSEcCtD
Darunavir—Fatigue—Epirubicin—testicular cancer	0.000278	0.000342	CcSEcCtD
Darunavir—Pain—Epirubicin—testicular cancer	0.000275	0.000339	CcSEcCtD
Darunavir—Constipation—Epirubicin—testicular cancer	0.000275	0.000339	CcSEcCtD
Darunavir—Urticaria—Methotrexate—testicular cancer	0.000273	0.000337	CcSEcCtD
Darunavir—Body temperature increased—Methotrexate—testicular cancer	0.000272	0.000335	CcSEcCtD
Darunavir—Abdominal pain—Methotrexate—testicular cancer	0.000272	0.000335	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000271	0.000334	CcSEcCtD
Darunavir—Insomnia—Doxorubicin—testicular cancer	0.000269	0.000332	CcSEcCtD
Darunavir—Paraesthesia—Doxorubicin—testicular cancer	0.000267	0.000329	CcSEcCtD
Darunavir—Dyspnoea—Doxorubicin—testicular cancer	0.000266	0.000327	CcSEcCtD
Darunavir—Feeling abnormal—Epirubicin—testicular cancer	0.000265	0.000327	CcSEcCtD
Darunavir—Somnolence—Doxorubicin—testicular cancer	0.000265	0.000326	CcSEcCtD
Darunavir—Gastrointestinal pain—Epirubicin—testicular cancer	0.000263	0.000324	CcSEcCtD
Darunavir—Dyspepsia—Doxorubicin—testicular cancer	0.000262	0.000323	CcSEcCtD
Darunavir—Decreased appetite—Doxorubicin—testicular cancer	0.000259	0.000319	CcSEcCtD
Darunavir—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000257	0.000317	CcSEcCtD
Darunavir—Fatigue—Doxorubicin—testicular cancer	0.000257	0.000316	CcSEcCtD
Darunavir—Urticaria—Epirubicin—testicular cancer	0.000256	0.000315	CcSEcCtD
Darunavir—Pain—Doxorubicin—testicular cancer	0.000255	0.000314	CcSEcCtD
Darunavir—Constipation—Doxorubicin—testicular cancer	0.000255	0.000314	CcSEcCtD
Darunavir—Body temperature increased—Epirubicin—testicular cancer	0.000254	0.000313	CcSEcCtD
Darunavir—Abdominal pain—Epirubicin—testicular cancer	0.000254	0.000313	CcSEcCtD
Darunavir—Hypersensitivity—Methotrexate—testicular cancer	0.000253	0.000312	CcSEcCtD
Darunavir—Asthenia—Methotrexate—testicular cancer	0.000247	0.000304	CcSEcCtD
Darunavir—Feeling abnormal—Doxorubicin—testicular cancer	0.000245	0.000302	CcSEcCtD
Darunavir—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000244	0.0003	CcSEcCtD
Darunavir—Pruritus—Methotrexate—testicular cancer	0.000243	0.0003	CcSEcCtD
Darunavir—Hypersensitivity—Epirubicin—testicular cancer	0.000237	0.000292	CcSEcCtD
Darunavir—Urticaria—Doxorubicin—testicular cancer	0.000237	0.000291	CcSEcCtD
Darunavir—Abdominal pain—Doxorubicin—testicular cancer	0.000235	0.00029	CcSEcCtD
Darunavir—Body temperature increased—Doxorubicin—testicular cancer	0.000235	0.00029	CcSEcCtD
Darunavir—Diarrhoea—Methotrexate—testicular cancer	0.000235	0.00029	CcSEcCtD
Darunavir—Asthenia—Epirubicin—testicular cancer	0.000231	0.000285	CcSEcCtD
Darunavir—Pruritus—Epirubicin—testicular cancer	0.000228	0.000281	CcSEcCtD
Darunavir—Dizziness—Methotrexate—testicular cancer	0.000227	0.00028	CcSEcCtD
Darunavir—Diarrhoea—Epirubicin—testicular cancer	0.00022	0.000271	CcSEcCtD
Darunavir—Hypersensitivity—Doxorubicin—testicular cancer	0.000219	0.00027	CcSEcCtD
Darunavir—Vomiting—Methotrexate—testicular cancer	0.000219	0.000269	CcSEcCtD
Darunavir—Rash—Methotrexate—testicular cancer	0.000217	0.000267	CcSEcCtD
Darunavir—Dermatitis—Methotrexate—testicular cancer	0.000217	0.000267	CcSEcCtD
Darunavir—Headache—Methotrexate—testicular cancer	0.000216	0.000265	CcSEcCtD
Darunavir—Asthenia—Doxorubicin—testicular cancer	0.000214	0.000263	CcSEcCtD
Darunavir—Dizziness—Epirubicin—testicular cancer	0.000213	0.000262	CcSEcCtD
Darunavir—Pruritus—Doxorubicin—testicular cancer	0.000211	0.00026	CcSEcCtD
Darunavir—Vomiting—Epirubicin—testicular cancer	0.000205	0.000252	CcSEcCtD
Darunavir—Nausea—Methotrexate—testicular cancer	0.000204	0.000252	CcSEcCtD
Darunavir—Diarrhoea—Doxorubicin—testicular cancer	0.000204	0.000251	CcSEcCtD
Darunavir—Rash—Epirubicin—testicular cancer	0.000203	0.00025	CcSEcCtD
Darunavir—Dermatitis—Epirubicin—testicular cancer	0.000203	0.00025	CcSEcCtD
Darunavir—Headache—Epirubicin—testicular cancer	0.000202	0.000248	CcSEcCtD
Darunavir—Dizziness—Doxorubicin—testicular cancer	0.000197	0.000243	CcSEcCtD
Darunavir—Nausea—Epirubicin—testicular cancer	0.000191	0.000236	CcSEcCtD
Darunavir—Vomiting—Doxorubicin—testicular cancer	0.000189	0.000233	CcSEcCtD
Darunavir—Rash—Doxorubicin—testicular cancer	0.000188	0.000231	CcSEcCtD
Darunavir—Dermatitis—Doxorubicin—testicular cancer	0.000188	0.000231	CcSEcCtD
Darunavir—Headache—Doxorubicin—testicular cancer	0.000187	0.00023	CcSEcCtD
Darunavir—Nausea—Doxorubicin—testicular cancer	0.000177	0.000218	CcSEcCtD
